Solving the mystery of excessive warfarin-induced bleeding: A personal historical perspectiveHIRSH, Jack.Thrombosis and haemostasis. 2014, Vol 112, Num 5, pp 853-856, issn 0340-6245, 4 p.Article

The chemistry and biology of bicoumarinsHUSSAIN, Hidayat; HUSSAIN, Javid; AL-HARRASI, Ahmed et al.Tetrahedron (Oxford. Print). 2012, Vol 68, Num 12, issn 0040-4020, 2545, 2553-2578 [27 p.]Article

Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patientsFIRRIOLO, F. John; HUPP, Wendy S.Oral surgery, oral medicine, oral pathology and oral radiology (Print). 2012, Vol 113, Num 4, pp 431-441, issn 2212-4403, 11 p.Article

Using Pharmacogenetics in Real Time to Guide Warfarin Initiation: A Clinician UpdateCARLQUIST, John F; ANDERSON, Jeffrey L.Circulation (New York, N.Y.). 2011, Vol 124, Num 23, pp 2554-2559, issn 0009-7322, 6 p.Article

Who is responsible for the care of patients treated with warfarin therapy?LOWTHIAN, Judy A; DIUG, Basia O; EVANS, Sue M et al.Medical journal of Australia. 2009, Vol 190, Num 12, pp 674-677, issn 0025-729X, 4 p.Article

Pharmacogenomics of coumarin anticoagulants : Are we underestimating the role of CYP2C9?SCHALEKAMP, Tom; MAITLAND -VAN DER ZEE, Anke-Hilse; DE BOER, Anthonius et al.Thrombosis and haemostasis. 2008, Vol 100, Num 2, pp 175-176, issn 0340-6245, 2 p.Article

Differential Inhibition of Cytochromes P450 3A4 and 3A5 by the Newly Synthesized Coumarin Derivatives 7-Coumarin Propargyl Ether and 7-(4-Trifluoromethyl)coumarin Propargyl EtherSRIDAR, Chitra; KENT, Ute M; NOON, Kate et al.Drug metabolism and disposition. 2008, Vol 36, Num 11, pp 2234-2243, issn 0090-9556, 10 p.Article

Anaerobic p-Coumarate Degradation by Rhodopseudomonas palustris and Identification of CouR, a MarR Repressor Protein That Binds p-Coumaroyl Coenzyme AHIRAKAWA, Hidetada; SCHAEFER, Amy L; GREENBERG, E. Peter et al.Journal of bacteriology. 2012, Vol 194, Num 8, pp 1960-1967, issn 0021-9193, 8 p.Article

Cranberry Juice and Warfarin: When Bad Publicity Trumps ScienceZIKRIA, Jennifer; GOLDMAN, Raimonda; ANSELL, Jack et al.The American journal of medicine. 2010, Vol 123, Num 5, pp 384-392, issn 0002-9343, 9 p.Article

Patients Benefit From Genetics-Guided Coumarin Anticoagulant TherapyMAITLAND-VAN DER ZEE, A. H; DALY, A. K; KAMALI, F et al.Clinical pharmacology and therapeutics. 2014, Vol 96, Num 1, pp 15-17, issn 0009-9236, 3 p.Article

New oral anticoagulants: will they replace warfarin?LITTLE, James W.Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2012, Vol 113, Num 5, pp 575-580, issn 1079-2104, 6 p.Article

Pharmacogenomic Considerations for Customizing Warfarin Therapy in the Orthopedic PatientRHEE, Sonja; WALSH, Kelly; LEWIS, Daniel et al.Orthopedics (Thorofare). 2010, Vol 33, Num 11, pp 828-831, issn 0147-7447, 4 p.Article

CYP4F2 genetic variant alters required warfarin doseCALDWELL, Michael D; AWAD, Tarif; KING, Cristi R et al.Blood. 2008, Vol 111, Num 8, pp 4106-4112, issn 0006-4971, 7 p.Article

Genetic Determinants of Response to Warfarin during Initial AnticoagulationSCHWARZ, Ute I; RITCHIE, Marylyn D; BRADFORD, Yuki et al.The New England journal of medicine. 2008, Vol 358, Num 10, pp 999-1008, issn 0028-4793, 10 p.Article

A Bayesian Dose-Individualization Method for WarfarinWRIGHT, Daniel F. B; DUFFULL, Stephen B.Clinical pharmacokinetics. 2013, Vol 52, Num 1, pp 59-68, issn 0312-5963, 10 p.Article

Warfarin-induced skin necrosisMUNGALSINGH, Catherine R; BOMFORD, Jamie; NAYAGAM, Jeremy et al.Clinical medicine. 2012, Vol 12, Num 1, pp 90-91, issn 1470-2118, 2 p.Article

Factor VII Levels and International Normalized Ratios in the Early Phase of Warfarin TherapyBENZON, Honorio T; AVRAM, Michael J; BENZON, Hubert A et al.Anesthesiology (Philadelphia). 2010, Vol 112, Num 2, pp 298-304, issn 0003-3022, 7 p.Article

Provision of warfarin education to hospital inpatientsBAUGHMAN, Christopher; SPURLING, Lisa; MANGONI, Arduino A et al.British journal of clinical pharmacology. 2008, Vol 66, Num 3, pp 416-417, issn 0306-5251, 2 p.Article

The story of the discovery of heparin and warfarinWARDROP, Douglas; KEELING, David.British journal of haematology. 2008, Vol 141, Num 6, pp 757-763, issn 0007-1048, 7 p.Article

Probable Interaction Between Warfarin and TorsemideBIRD, Jennifer; CARMONA, Carlos.The Annals of pharmacotherapy. 2008, Vol 42, Num 12, pp 1893-1898, issn 1060-0280, 6 p.Article

Warfarin Dosing and Body Mass IndexMUELLER, Julia A; PATEL, Tulsi; HALAWA, Ahmad et al.The Annals of pharmacotherapy. 2014, Vol 48, Num 5, pp 584-588, issn 1060-0280, 5 p.Article

Study on the interaction between gliadins and a coumarin as molecular model system of the gliadins-anthocyanidins complexesTOZZI, Silvia; ZANNA, Nicola; TADDEI, Paola et al.Food chemistry. 2013, Vol 141, Num 4, pp 3586-3597, issn 0308-8146, 12 p.Article

A Randomized and Clinical Effectiveness Trial Comparing Two Pharmacogenetic Algorithms and Standard Care for Individualizing Warfarin Dosing (CoumaGen-II)ANDERSON, Jeffrey L; HOME, Benjamin D; HUNTINGHOUSE, John A et al.Circulation (New York, N.Y.). 2012, Vol 125, Num 16, pp 1997-2005, issn 0009-7322, 9 p.Article

Influence of CYP4F2 genotype on warfarin dose requirement-a systematic review and meta-analysisRUIJUAN LIANG; CHUNLING WANG; HONG ZHAO et al.Thrombosis research. 2012, Vol 130, Num 1, pp 38-44, issn 0049-3848, 7 p.Article

Identification, synthesis and quantification of process-related impurities in aurapteneLI, Yan-Gang; CHEN, Hai-Fang; TU, Ming-Zhu et al.Journal of pharmaceutical and biomedical analysis. 2011, Vol 56, Num 2, pp 191-199, issn 0731-7085, 9 p.Article